WHO ICTRP trial
A Study to Evaluate CTX-712 in Advanced, Relapsed or Refractory Malignant Cancer…
JPRN-jRCT2080224127 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2080224127 |
|---|---|
| Public title | A Study to Evaluate CTX-712 in Advanced, Relapsed or Refractory Malignant Cancer Patients |
| Scientific title | A Study to Evaluate CTX-712 in Advanced, Relapsed or Refractory Malignant Cancer Patients |
| Primary sponsor | Chordia Therapeutics Inc. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan |
| Conditions | Advanced,relapsed or refractory cancers |
| Interventions | investigational material(s) Generic name etc : CTX-712 INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Cohort A (Dose Escalation Cohort… |
| Registration date | Oct 30, 2018 |
| Target size | 79 |
| Secondary IDs | JapicCTI-184188 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: